Logo image of LCTX

LINEAGE CELL THERAPEUTICS IN (LCTX) Stock News

NYSEARCA:LCTX - NYSE Arca - US53566P1093 - Common Stock - Currency: USD

0.6829  -0.02 (-2.26%)

Premarket: 0.6754 -0.01 (-1.1%)

LCTX Latest News, Press Relases and Analysis

News Image
16 days ago - Zacks Investment Research

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of 15.69% and 385.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: EDIT

News Image
4 months ago - Lineage Cell Therapeutics, Inc.

Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury

News Image
5 months ago - Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics Issues Letter to Stockholders

News Image
10 months ago - InvestorPlace

LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q2 2024

LCTX stock results show that Lineage Cell Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

News Image
a year ago - Lineage Cell Therapeutics, Inc.

Lineage to Present at 2024 BIO International Convention